Poland· PL-100415034

Cyclo 3 Fort

A medicinal product containing produkt złożony, registered in Poland by Pharmapoint SA.

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCyclo 3 FortATC—REGISTER NO.PL-100415034PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Produkt złożony
Manufacturer
Pharmapoint SA
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991392413
  • gtin
    05909991392420

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e9d41491-e519-4199-b8c1-15e7da69f90d
GET /v1/drugs/e9d41491-e519-4199-b8c1-15e7da69f90d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "150 mg + 150 mg + 100 mg",
  "packaging": "05909991392413 ¦ OTC ¦ 130925\n30 kaps.\n05909991392420 ¦ OTC ¦ 130926\n60 kaps.",
  "substance": null,
  "common_name": "Produkt złożony",
  "pl_product_id": "100415034",
  "pozwolenie_nr": "41/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2024-01-31"
}

See everything about produkt złożony.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.